This could go mental once news hits US overnight. Pfizer might not be too pleased, assuming I have got it right that they make it. SOI and mkt cap as has been said, provide a serious springboard
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-51
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
-0.030(4.29%) |
Mkt cap ! $7.602M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 70.0¢ | 67.0¢ | $1.548K | 2.246K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4350 | 67.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.0¢ | 229 | 1 |
View Market Depth
| Last trade - 15.45pm 13/09/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |